E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes

NCT01692197 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: E7070
DRUG: Idarubicin
DRUG: Cytarabine
DRUG: Dexamethasone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]